Below are the valuation targets for Cisco Systems (CSCO) for the next 10 years. Continue reading
- Japan
- Market Indicator
- Price Momentum Indicators
- Richard Russell
- Silver
- Speed Resistance Lines
- U.S. Dividend Watch List
Below are the valuation targets for Cisco Systems (CSCO) for the next 10 years. Continue reading
Below are the valuation targets for Cisco Systems (CSCO) for the next 10 years. Continue reading
Performance Review
Below is the performance of the six stocks from the February 21, 2014 Nasdaq 100 watch list compared to the Nasdaq 100 Index gain of +15.46%.
|
Symbol
|
Name |
2014 | 2015 | change |
| SYMC | Symantec Corporation | $20.53 | $24.77 | 20.65% |
| MAT | Mattel, Inc. | $35.55 | $28.22 | -20.62% |
| CHRW | CH Robinson Worldwide | $54.12 | $70.51 | 30.28% |
| FAST | Fastenal Company | $45.61 | $42.33 | -7.19% |
| SPLS | Staples, Inc. | $13.09 | $16.57 | 26.59% |
| CSCO | Cisco Systems, Inc. | $22.13 | $27.24 | 23.09% |
The average gain for all of the stocks was +12.13%. Symantec (SYMC) was the stock of interest at the time. Our thoughts on SYMC were, “…we don’t see why the stock couldn’t decline a bit further until April or May.” In fact, SYMC declined as low as $17.95, a drop of –12.57%. However, the final low occurred in late March instead of the April/May projection.
At the time of the posting from last year, we outlined the analyst estimated price change for six stocks on our watch list. The projections were as follows:
![]()
The actual performance after one year is displayed below.
On the whole, it appears that the analysts were correct about the overall trend for the stocks on our watch list. two of three were (MAT, CHRW and FAST) were expected to be a mixed bag while three of three (CSCO, SYMC and SPLS) were expected to have price increases.
February 6, 2015 Watch List
Below are the 14 Nasdaq 100 companies that are on our radar. As readers know, we have recently taken a sizable position in one of the stocks on this list.
The question of retaining profits on quality dividend companies through the selling of a position seems to counter the whole point of dividend investing. After all, aren’t you supposed to allow the dividends to compound? In a small way, we described one approach and our rational for selling quality companies after small gains in yesterday’s article (Our Primary Concern: Retaining Profits).
However, there is another way to view the rationale behind selling a dividend stock after a “fair profit.” In the early years of the Dow Theory Letters, Richard Russell would often cite a Robert Rhea quote about the impact of a stock decline. Rhea said:
“’Buying in bear markets is merely gambling and not very good gambling at that. Why not have cash instead of investments in bear markets? Why insist that one cannot afford to forego investment income when one day’s price shrinkage may cancel several years’ dividends?’”
![]() |
| Source: Richard Russell, Dow Theory Letters, http://www.dowtheoryletters.com/ |
Because stocks are not required to return principal with a stated yield as with many bonds, there is no assurance that the price will recover to the level that a purchase was initiated. Therefore, receiving short-term income on a dividend stock, although a necessary source of income for retired individuals, the prospect exists that an investor could end up with only a portion of the principal instead of the intended income plus principal.
The lack of assurance of principal and income with dividend stocks is why we believe people have become disenfranchised with technology stocks like Microsoft (MSFT) and Cisco Systems (CSCO). If they’ve invested in the stocks with the belief that they’re in it forever, when the decline comes, absent any dividend, there is little recourse or hope of recovering lost funds or keeping up with inflation.
Even new investors to Microsoft and Cisco Systems, aware of their bold promises in 1999 and subsequent failure to deliver in 2011, are asking themselves, “is it really worth facing the prospect of no return?” These questions are being asked when in some instances, especially with Microsoft, the timing probably couldn’t be better (especially now that they’re paying a dividend). Our supplementary comments on Microsoft can be found here.
While we subscribe to the Graham/Buffett principles of investing (buying for the long-term, you’re buying a business, concentrate on values, etc.) we assume that since there are only a handful of billionaires hewn strictly from investing in stocks, we might do well to hedge our thinking and strategy.
Finally, further analysis of Robert Rhea’s claim on not being invested at all during bear markets is something that is at odds with Charles Dow and we’ve decided is not appropriate or necessary. From our experience, bear markets are no guarantee of losses in your portfolio. Charles H. Dow, founder of the Wall Street Journal, has said that:
"Even in a bear market, this method of trading will usually be found safe, although the profits taken should be less because of the liability of weak spots breaking out and checking the general rise."
Schultz, Harry D., A Treasury of Wall Street Wisdom, Investors' Press, (New Jersey, 1966). p. 12. Additional commentary here.
Evidence of the fact that bear markets don’t always equal destruction of wealth, while going long stocks, is demonstrated in our 2007, 2008 and 2009 performance review. Naturally, 2008 is not expected to be replicated (having gains, while going long only, during a market decline of 40% or more). However, we do know that being all in or timing the market to be all out during bear markets shouldn’t be the goal. The goal, from our perspective, should be the preservation of gains whenever possible.
Posted in CSCO, Dow Theory, Harry Schultz, MSFT, Richard Russell, Robert Rhea
| Symbol | Name | Price | P/E | EPS | Yield | P/B | % from Low |
| CSCO | Cisco Systems, Inc. | $18.85 | 14.26 | $1.32 | 0 | 2.26 | 1.56% |
| AMGN | Amgen Inc. | $52.24 | 10.91 | $4.79 | 0 | 2.04 | 3.94% |
| CEPH | Cephalon, Inc. | $58.63 | 11.13 | $5.27 | 0 | 1.68 | 6.60% |
| TEVA | Teva Pharma. | $51.89 | 14.16 | $3.66 | 1.70% | 2.13 | 10.43% |
| ATVI | Activision Blizzard, Inc | $11.07 | 33.55 | $0.33 | 1.50% | 1.3 | 10.81% |
| CELG | Celgene Corp. | $53.47 | 28.44 | $1.88 | 0 | 4.79 | 11.35% |
| EXPE | Expedia, Inc. | $20.96 | 14.36 | $1.46 | 1.30% | 2.15 | 14.54% |
| MSFT | Microsoft Corp. | $27.06 | 11.55 | $2.34 | 2.40% | 4.72 | 19.05% |
| MICC | Millicom Intl. Cellular | $90.27 | 5.92 | $15.24 | 2.60% | 3.06 | 19.86% |
Watch List Performance Review
| Symbol | Name | 2010 | 2011 | Change |
| APOL | Apollo Group | $56.92 | $45.82 | -19.50% |
| ERTS | Electronic Arts | $16.75 | $19.28 | 15.10% |
| FSLR | First Solar | $116.00 | $168.22 | 45.02% |
| ATVI | Activision | $10.79 | $11.07 | 2.59% |
| PPDI | Pharma Prod. | $21.20 | $27.97 | 31.93% |
| SRCL | Stericycle | $54.30 | $87.38 | 60.92% |
| GENZ | Genzyme | $55.97 | $75.38 | 34.68% |
| GILD | Gilead | $48.84 | $39.30 | -19.53% |
| Average | 18.90% | |||
| NDX | Nasdaq 100 | 1823.32 | 2392.47 | 31.22% |
| Symbol | Name | Price | P/E | EPS | Yield | P/B | % from Low |
| ISRG | Intuitive Surgical | $267.40 | 31.8 | $8.40 | - | 5.26 | 8.68% |
| CEPH | Cephalon, Inc. | $60.32 | 11.3 | $5.35 | - | 1.81 | 9.67% |
| CSCO | Cisco Systems | $20.97 | 15.4 | $1.36 | - | 2.62 | 10.37% |
| APOL | Apollo Group, Inc. | $37.98 | 10.5 | $3.62 | - | 4.30 | 12.54% |
| AMGN | Amgen Inc. | $56.98 | 12.3 | $4.63 | - | 2.24 | 13.37% |
| ERTS | Electronic Arts | $16.05 | - | -$0.48 | - | 2.04 | 14.17% |
| QGEN | Qiagen N.V. | $19.32 | 30.4 | $0.64 | - | 1.89 | 14.59% |
| TEVA | Teva Pharma. | $54.01 | 16.6 | $3.25 | 1.30% | 2.22 | 14.94% |
| VRTX | Vertex Pharma. | $36.16 | - | -$3.73 | - | 11.31 | 15.71% |
| GRMN | Garmin Ltd. | $30.53 | 8.3 | $3.66 | 4.80% | 2.10 | 16.93% |
| INTC | Intel Corporation | $20.66 | 11.2 | $1.85 | 3.00% | 2.43 | 17.39% |
| GILD | Gilead Sciences | $37.50 | 11.0 | $3.42 | - | 5.36 | 18.18% |
| SHLD | Sears Holdings | $70.18 | 41.9 | $1.68 | - | 0.94 | 18.53% |
| ^NDX | Nasdaq 100 | 2,276.70 | |||||
| Symbol | Name | 2010 | 2011 | % change |
| GILD | Gilead Sciences | 44.54 | 37.50 | -15.81% |
| CEPH | Cephalon, Inc. | 63.01 | 60.32 | -4.27% |
| GENZ | Genzyme Corp | 53.81 | 71.39 | 32.67% |
| APOL | Apollo Group | 60.50 | 37.98 | -37.22% |
| Average | -6.16% | |||
| ^NDX | Nasdaq 100 | 1892.59 | 2276.70 | 20.30% |